Glaucoma
📧 Sign up to get email alerts when something new happens for Glaucoma.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2016-03-24FDA Approved: BETOPTIC S — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Betoptic S (betaxolol hydrochloride) from Novartis, updating the drug's labeling.
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery? [Phase 2, Phase 3]
This clinical trial update reports Phase 2 and Phase 3 studies evaluating Triesence (triamcinolone acetonide) used during glaucoma surgery t…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Quality of Life in Children Glaucoma and Cataract
This completed clinical trial evaluated quality of life in children with glaucoma and cataracts. It was sponsored by Moorfields Eye Hospital…
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Glaucoma HFA / OCT Specificity Study
A clinical trial update for a glaucoma imaging study evaluating HFA and OCT specificity. Sponsor: Carl Zeiss Meditec, Inc.
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Health Coaching for Glaucoma Patients [NA]
A Duke University–sponsored clinical trial evaluated health coaching for patients with glaucoma, and results were posted in March 2016.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2016-03-11FDA Approved: TRAVATAN Z — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Travatan Z (travoprost) from Novartis Pharmaceuticals Corporation. This action updates the produ…
-
CLINICAL_TRIALS research · 2016-03-07Clinical Trial Update: Relation Between Macular and RNFL Thickness Measurement and Quality Grading in OCT [NA]
An update on a clinical trial investigating the relationship between macular and retinal nerve fiber layer thickness measurements and OCT qu…
-
CLINICAL_TRIALS research · 2016-02-26Clinical Trial Update: Evaluation of Corneal Temperature by Infrared Thermography in Glaucoma Patients [NA]
A completed clinical study from University Hospital Basel evaluating corneal temperature in glaucoma patients using infrared thermography.
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: AqueSys Microfistula Implant in Refractory Glaucoma [Phase 3]
Phase 3 trial of the AqueSys Microfistula Implant for refractory open-angle glaucoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-28Clinical Trial Update: Diurnal Fluctuations of Intraocular Pressure in EX-Press Valve Blebs in Glaucoma Patients
This clinical trial update investigates diurnal fluctuations of intraocular pressure in glaucoma patients implanted with EX-Press valve bleb…
-
FDA label_change · 2016-01-21FDA Approved: MIOSTAT — Supplemental Application (Alcon Laboratories, Inc.)
The FDA approved a supplemental application for MIOSTAT (carbachol) from Alcon Laboratories, Inc., updating the labeling for its ocular use.
-
FDA approval · 2016-01-19FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for brimonidine tartrate submitted by Sandoz Inc, resulting in changes to the product's labeling…
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye [Phase 4]
Phase 4 trial evaluating skin pigmentation changes near the eye in glaucoma patients treated with Xalatan, Travatan, or Lumigan.
-
FDA label_change · 2016-01-15FDA Approved: SIMBRINZA — Supplemental Application (Alcon Laboratories, Inc.)
The FDA approved a supplemental application for SIMBRINZA (brinzolamide/brimonidine tartrate) to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 trial comparing bimatoprost 0.01% alone with travoprost 0.004% and timolol 0.5% in glaucoma or ocular hypertension. Results were pos…
-
CLINICAL_TRIALS trial_result · 2016-01-07Clinical Trial Update: IOP Changes Associated With SICS and Phako [EARLY_Phase 1]
Early-phase clinical trial update reports intraocular pressure (IOP) changes observed after cataract surgery techniques SICS and phacoemulsi…
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma [Phase 4]
A Phase 4 study evaluating intravitreal ranibizumab as adjuvant therapy for postvitrectomy diabetic vitreous hemorrhage with neovascular gla…
-
CLINICAL_TRIALS trial_result · 2015-12-29Clinical Trial Update: Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis [Phase 3]
Phase 3 trial evaluating intravitreal aflibercept vs ranibizumab for rubeosis iridis in glaucoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-28Clinical Trial Update: Eye Drop Application Monitor, Pilot Study
Pilot clinical trial update of an Eye Drop Application Monitor for patients requiring ophthalmic drops. The status of the trial is unknown a…
-
CLINICAL_TRIALS trial_result · 2015-11-30Clinical Trial Update: An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 trial comparing efficacy and safety of bimatoprost 0.01% alone with travoprost 0.004% and timolol 0.5% in glaucoma or ocular hyperte…
-
CLINICAL_TRIALS trial_result · 2015-11-30Clinical Trial Update: Drinking Habits of Glaucoma Patients and Age Matched Controls
Completed clinical trial examining drinking habits and dehydration in glaucoma patients compared with age-matched controls.
-
FDA approval · 2015-11-27FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd.)
The FDA approved Advagen Pharma Ltd.'s supplemental application for dorzolamide hydrochloride, authorizing a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: Tube Versus Trabeculectomy (TVT) Study [NA]
The Tube Versus Trabeculectomy (TVT) Study in glaucoma has completed, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema
The clinical trial evaluated retinal nerve fiber layer thickness by optical coherence tomography in patients with uveitis and papilledema; t…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial evaluating the efficacy and safety of OPC-1085EL ophthalmic solution in glaucoma or ocular hypertension has completed and resu…